Summary
Zoetis Inc. (ZTS) filed an 8-K on June 10, 2013, detailing new severance provisions for its Chief Executive Officer (CEO) and other Executive Officers, which will become effective upon Pfizer Inc. ceasing to own a controlling interest in Zoetis. The severance plan offers benefits in cases of termination without cause or resignation for good reason following a Change in Control (CIC). Notably, severance multiples for salary and target bonus are higher in the event of a CIC, with the CEO receiving 2.5 times salary and bonus, and other Executive Officers receiving 2 times salary and bonus, compared to 1.5 times for the CEO and 1 times for other officers in a non-CIC triggering event. These provisions aim to provide financial security and incentivize continued performance during a period of significant corporate transition. In addition to the severance plan, the filing also announced adjustments to the compensation of Zoetis' CEO, Juan Ramón Alaix. Effective July 1, 2013, his annual base salary will increase from $750,000 to $900,000, and his annual target bonus percentage will rise from 100% to 110% of his base salary. These changes are intended to align executive compensation with evolving company needs and responsibilities, particularly in anticipation of potential changes in ownership structure and strategic direction. Investors should note that the full details of the Severance Plan are expected to be disclosed in the Company's subsequent Form 10-Q filing.
Key Highlights
- 1Zoetis adopted a new Severance Plan for its CEO and Executive Officers, effective when Pfizer's controlling interest ends.
- 2Severance benefits are triggered by termination without "Cause" or resignation for "Good Reason" within 24 hours of a "Change in Control" (CIC).
- 3In a non-CIC triggering event, the CEO receives 1.5x salary and bonus; other Executive Officers receive 1x salary and bonus.
- 4In a CIC triggering event, the CEO receives 2.5x salary and bonus; other Executive Officers receive 2x salary and bonus.
- 5Both CEO and Executive Officers are eligible for up to 12 months (non-CIC) or 18 months (CIC) of continued health insurance coverage at active employee rates.
- 6CEO Juan Ramón Alaix's base salary will increase to $900,000 from $750,000, effective July 1, 2013.
- 7CEO Juan Ramón Alaix's target bonus will increase to 110% of base salary from 100%, effective July 1, 2013.